Dr. Luu V. Van Pham

Matthew Lammi, MD MSCR is an Associate Professor of Medicine and part of the Interstitial Lung Disease (ILD) Program. Dr. Lammi obtained his medical degree from Temple University School of Medicine and did his internal medicine, pulmonary, and critical care training at Temple University Hospital. He then joined the faculty at LSU in New Orleans, where he served as the Director of the Comprehensive Pulmonary Hypertension Center. He joined Johns Hopkins in 2023. He currently serves as the Associate Director of the Johns Hopkins Pulmonary Fibrosis Foundation Care Center and is the Associate Program Director for the Advanced Lung Disease Fellowship. His research focuses on the intersection between ILD and pulmonary hypertension, particularly in patients with systemic sclerosis. He is currently a co-Principal Investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is active in numerous societies and serves as the Chair of the Research Committee for the Pulmonary Hypertension Association. Dr. Lammi is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Sarcoidosis, Scleroderma, Systemic Sclerosis (SSc), and Lung Transplant. Dr. Lammi is board certified in American Board Of Internal Medicine. Dr. Lammi is currently accepting new patients.

Dr. Yarmus is a Professor of Medicine and Oncology and the director of Interventional Pulmonology at the Johns Hopkins University School of Medicine as well as the Vice Chair of Medicine for Strategy and Finance. He is an expert in the minimally invasive diagnosis and treatment of lung cancer and he leads the Interventional Pulmonary research program at Johns Hopkins with research investigating innovative minimally invasive device development and early-stage bronchoscopic treatments. He also has extensive experience in the minimally invasive management of malignant airway obstruction, complex airway management, pleural diseases and symptom relief with minimally invasive procedures such as indwelling pleural catheters and pleurodesis. Dr. Yarmus is a member of the Fleischner Society and a fellow of the American College of Chest Physicians and the American Thoracic Society. Dr. Yarmus is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Pleural Effusion, Lung Nodules, Lung Cancer, Endoscopy, and Advanced Bronchoscopy. Dr. Yarmus is currently accepting new patients.

Dr. Lee is a specialist in Interventional Pulmonary and serves as the Wang Interventional Pulmonary Fellowship Director. His areas of clinical expertise include interventional pulmonology, pleural disease, minimal invasive diagnostics and lung cancer at Johns Hopkins. He also has extensive experience in the minimally invasive management of malignant airway obstruction, complex airway management and difficulty airways. In addition, he specializes in the diagnosis and management of pleural diseases and symptom relief with minimally invasive procedures. He is a fellow of the American College of Chest Physicians and the Johns Hopkins Master of Education for Health Professionals. Dr. Lee is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Pleural Effusion, Lung Nodules, Lymphofollicular Hyperplasia, Endoscopy, and Advanced Bronchoscopy. Dr. Lee is board certified in American Board Of Internal Medicine. Dr. Lee is currently accepting new patients.

Dr. McCormack is a pulmonary, critical care physician and Associate Director of the Pulmonary & Critical Care Medicine Division. She is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. She has expertise in pulmonary physiology. She serves as the Medical Director of the Johns Hopkins University Pulmonary Function Laboratory and as the Chair of the American Thoracic Society Pulmonary Function Test Committee. She earned her M.D. from Jefferson Medical College of Thomas Jefferson University and her M.H.S. from the Bloomberg School of Public Health. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. She was the recipient of the Frederick L. Brancati Excellence in Mentoring Award. She plays an active role in mentoring fellows and junior faculty in the Pulmonary & Critical Care Medicine Division. Dr. Mccormack is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Asthma, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant. Dr. Mccormack is board certified in American Board Of Internal Medicine. Dr. Mccormack is currently accepting new patients.

Dr. Christopher Earley's research and clinical interests are devoted to Sleep Medicine with a special interest in Restless Legs Syndrome. His current research is focused on understanding the pathophysiology of Restless Legs Syndrome and further elucidating the value of various treatments in this syndrome. Dr. Earley received his medical degree as well as a PhD in Pharmacology from the University College in Galway, Ireland. He completed a full residency in Internal Medicine at Baylor Medical College and then went to the University of Virginia in Charlottesville to complete his residency in Neurology. After then spending a year at the NIH as a fellow in the Neurobiology Unit, Dr. Earley joined the faculty at Johns Hopkins in 1991. 2008 Professor, Department of Neurology, Johns Hopkins 1994- Associate Director, Sleep Disorders Center, JHBMC Education and Training: 1973 - B.S. (General), Villanova University 1974 - B.A. (Psychology), Arizona State University 1978 - Ph.D. (Pharmacology), National University of Ireland 1983 - M.B., B.Ch. ( Medicine), National University of Ireland 1983-1984 Internship, University Hospital, Galway, Ireland 1984-1987 Resident in Internal Medicine, Baylor College of Medicine, Houston, TX 1987-1990 Resident in Neurology, University of Virginia, Charlottesville, VA 1990-1991 Senior Staff Fellow, Neurobiology Unit, NIH/NIA Professional Experience: 1991- Full-time Staff Neurologist, Johns Hopkins 1992-1999 Assistant Professor, Department of Neurology, Johns Hopkins 1993-2001 Director, Acute Stroke Service, 1994- Associate Director, Sleep Disorders Center 1994-1999 Co-Director, Neurosciences Critical Care Unit 1996-2000 Director, Neurovascular Ultrasound Lab 1999-2008 Associate Professor, Department of Neurology, Johns Hopkins. Dr. Earley is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Restless Legs Syndrome, Periodic Limb Movement Disorder, Narcolepsy, Seizures, and Gastrostomy. Dr. Earley is board certified in American Board Of Psychiatry And Neurology and American Board Of Internal Medicine.

Paul M. Hassoun, M.D., is professor of medicine at the Johns Hopkins University School of Medicine and the director of the pulmonary hypertension program at Johns Hopkins Hospital. He received his medical degree from the Faculté de Médecine Lariboisière-Saint Louis at the University of Paris, France, completed an internship and residency at Brigham and Women’s Hospital and a fellowship in Pulmonary and Critical Care Medicine at Massachusetts General Hospital, both at Harvard Medical School. He was on faculty in the pulmonary division at New England Medical Center/Tufts University School of Medicine (Tufts-NEMC) in Boston, MA, until 2002 when he joined the division of pulmonary and critical care medicine at Johns Hopkins University. Dr. Hassoun has served or currently serves on numerous American Thoracic Society (ATS) assemblies and committees, including the Pulmonary Circulation Long Range Planning Committee, the Pulmonary Circulation Program Committee (for which he served as chair for 2008-2009), the ATS Scientific Advisory Council, Pulmonary Circulation Leadership Committee, and the American College of Chest Physicians Vascular Steering Committee. He served as the ATS Pulmonary Circulation chair (2011-2012) and on the ATS Publications Policy Committee. He was recently elected president of the Pulmonary Vascular Research Institute (PVRI; 2018-2019). Dr. Hassoun has held numerous editorial activities including serving on the editorial board of the American Journal of Respiratory and Critical Medicine (2010 to present), CHEST (2006-2015) and the European Respiratory Review (2008-2015). He currently serves as associate editor of the European Respiratory Journal (2013-present) and has served as associate editor for the Journal of Clinical Investigation (2017-2022). Dr. Hassoun is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Systemic Sclerosis (SSc), Cerebral Hypoxia, Pulmonary Veno-Occlusive Disease, and Lung Transplant. Dr. Hassoun is board certified in American Board Of Internal Medicine. Dr. Hassoun is currently accepting new patients.